| Literature DB >> 35355193 |
Wojciech Łabuś1, Diana Kitala2, Aurora Navarro3, Agnieszka Klama-Baryła2, Małgorzata Kraut2, Anna Sitkowska2, Wojciech Smętek2,4, Artur Kamiński5,6.
Abstract
A burn is a sudden injury which immediate or long-term consequences may be life-threatening for the patient. A mass disaster event may involve large numbers of severely burned patients. Patients of this type typically have a limited area of healthy, unburned skin from which an autologous split thickness skin graft could be collected. In a clinical situation of this type, it is necessary to use a particular skin substitute. Non-viable allogeneic human skin graft materials might be considered as the most suitable skin substitutes in the treatment of such patients. At present, Poland does not have a sufficient supply of human allogeneic skin graft materials to meet the needs arising from a sudden and unforeseen mass disaster. This study involved an analysis of selected mass disasters. From this an estimate was made from a verified casualty profile of the necessary minimum stock of human allogeneic skin graft materials. An insufficient amount of skin results from an inadequate number of skin donors, which in turn results from the current tissue donation system. Therefore, a proposal has been made for the organizational, legal and systemic changes required to improve the situation in Polish transplantology, with particular emphasis on skin donation. In order to achieve a strategic stock of human skin grafts, a tissue collecting transplantation team should be organized. The rights and obligations of the non-physician transplant team member should be extended. Proposals have been made for awareness campaigns (adverts, posters etc.) and educational schemes (educational video, lectures during transplant coordinator training, etc.). Finally, a proposal has been made for possible methods to deal with the logistic management of the allogeneic skin stock. The required, essential stock of human allogeneic skin in the event of a mass disaster has been estimated at 600,000 cm2.Entities:
Keywords: Fire mass disaster; Human allogeneic skin graft materials stock; Skin Bank
Year: 2022 PMID: 35355193 PMCID: PMC8967378 DOI: 10.1007/s10561-022-10001-z
Source DB: PubMed Journal: Cell Tissue Bank ISSN: 1389-9333 Impact factor: 1.522
Fig. 1Summary of the number of allogeneic skin graft materials retrieved by CLO in 2009–2020; a a summary of the number of donations presented in the form of a table; b a list of the areas of transplants produced and transplanted in individual years, presented in a graphical form
A brief description of the Act of July 1, 2005 on the collection, storage and transplanting of cells, tissues and organs (“Transplantation Act”) with subsequent changes (journal of laws of 2009, No. 141, item 1149)
| Act of July 1, 2005 on collection, storage and transplanting of cells, tissues and organs (“Transplantation Act”) | |
|---|---|
| Chapter | Brief description of the chapter |
| I | The first chapter contains general provisions, indicates the material scope of the act, which, pursuant to Art. 1 specifies the rules for the harvesting, storage and transplantation of cells, including: cells hematopoietic marrow, peripheral blood and umbilical cord blood, tissues, organs from a living donor or from a cadaver and testing, processing, storage and cell distribution as well as human tissues. It was also clearly indicated that for cells taken from a donor, tissues and organs cannot be demanded or accepted for payment, other material or personal benefit, stating that that the reimbursement of costs of collection, storage, processing, cell sterilization, distribution and transplantation, tissues or organs taken from a donor is not a payment and does not constitute a material or personal benefit within the meaning of the Act (Art. 3, Sects. |
| II | Chapter 2 of the Act under discussion regulates the issues relating to the procurement of cells, tissues or organs from a human corpse |
| III | Chapter 3 addresses the problem of procuring cells, tissues or organs from living donors |
| IV | Chapter 4 deals with the specific type of retrieval and transplantation of cells, tissues and organs |
| V | Chapter 5 deals with the donation of cells, tissues and organs or their parts |
| VI | Chapter 6 deals with the activity of tissue and cell banks |
| VII | Chapter 7 deals with cells, tissues and organs as well as referring to the marking, monitoring and safety criteria and quality of cells, tissues and organs |
| VIII | Chapter 8 deals with the organization and operation of the “Poltransplant" Center Organizational and Coordination Committee for transplantation, the National Banking Center Tissues and Cells and the National Transplant Council |
| IX | Chapter 9 deals with the supervision of application provisions of the Act, including the provision of information written on compliance audits with the provisions of Directive 2004/23/EC of the European Parliament and the Council of March 31, 2004 |
| X | Chapter 10 contains penal provisions, including dissemination of paid advertisements being criminalized sale, purchase or intermediation in sales for a consideration or the acquisition of a cell, tissue, or organ for the purpose of transplantation |
| XI | Chapter 11 concerns the changes in the binding regulations, namely in the Act of April 6, 1990 on the Police and in the Act of August 27, 2004 on health care claims financed from public funds |
| XII | Chapter 12 includes the transitional, adaptation and final provisions |
Fig. 2A proposal for a promotional poster as part of an awareness campaign. The picture is modeled on a school assignment and depicts two identicalimages of a small, smiling vampire. The purpose is to raise awareness in a fun way that the removal of tissues and organs does not leave any visible signs of disfigurement. Our own creation, based on a free vector downloaded from the website: www.freepik.com
Fig. 3A proposed promotional poster as part of an awareness campaign. The picture is modeled on the actions promoting waste segregation and recycling, the “zero waste” attitude. Our own creation, based on a free vector downloaded from the website: www.freepik.com
Fig. 4A proposed promotional poster as part of an awareness campaign. The picture is modeled on modified infinity symbol, with an integrated heart symbol. The whole is accompanied by commentary related to the need and the possibility of giving someone a chance for a new life
Fig. 5A proposed promotional poster as part of an awareness campaign. The picture aims to draw the attention of healthcare professionals to increasing the number of actual donors. Our own creation, based on free vector downloaded from the TPM DTI
Fig. 6The scheme of collaboration between multiple regional tissue procurement teams and various tissue banks. a An example of a situation in which the procurement team performed the tissue retrieval in northwestern Poland and then transferred the appropriate tissues to specialized, distant tissue banks, for example skin. b An example of a situation in which the procurement team performed the tissue retrieval at the forensic medicine department (ZMS) and then transferred the collected tissues to specialized, distant tissue bank
Probability-to-impact ratio matrix
| Probability | 5 | Almost certain | 5 | 10 | 15 | 20 | 25 |
| 4 | Probable | 4 | 8 | 12 | 16 | 20 | |
| 3 | Moderately possible | 3 | 6 | 9 | 12 | 15 | |
| 2 | Unlikely | 2 | 4 | 6 | 8 | 10 | |
| 1 | Nearly impossible | 1 | 2 | 3 | 4 | 5 | |
| Imperceptible | Insignificant | Moderate (Average) | Serious | Disastrous | |||
| 1 | 2 | 3 | 4 | 5 | |||
| Impact | |||||||
Planned responses to identified risks
| Risk response | Action |
|---|---|
| Risk avoidance | Active reaction, which consists in modifying the project implementation plans in such a way as to eliminate a given risk. The emergence of secondary risks should be investigated |
| Risk reduction | A response that consists in taking specific actions to reduce the likelihood or impact of a risk |
| Risk transfer | The reaction of transferring the effects of a risk to another entity |
| Emergency backup plan | Passive reaction. Created only for those identified risks that may arise during the project implementation, where the earlier development of a contingency plan can significantly reduce the costs of actions taken in response to the occurrence of a given unfavorable phenomenon |
| Risk acceptance | Passive reaction. Consists in accepting and bearing all the consequences resulting from the possible occurrence of an unfavorable phenomenon |
Risks identified in the area of permits, contracts and financing
| Risk area | Source/Stakeholder | Risk description | Risk assessment | Risk category | Undertaken/planned risk response |
|---|---|---|---|---|---|
| Legal permission/consent for the collection and storage of allogeneic skin | CLO—Director, Tissue Bank staff | Failure to obtain the consent of the Health Ministry and National Center for Tissue and Cell Banking for the collection and transplantation of allogeneic skin | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction |
| External hospital—skin retrieval during MOD | CLO—Director, Tissue Bank staff, transplant team of the CLO, | ||||
| Poltransplant (TCs) | No Access to allogeneic human skin | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction | |
| Contract with recovery unit (forensic facility) | CLO—Director, Tissue Bank staff, transplant team of the forensic facility | ||||
| No Access to allogeneic human skin | 20 | Likelihood—Likely, but impact disastrous | Risk reduction | ||
| Contract with transplant team (MDs) | CLO—Director, Tissue Bank staff,transplant team of the CLO | ||||
| Failure to perform tasks by the CLO transplant team. No access to biological material—allogeneic human skin | 20 | Likelihood—Likely, but impact disastrous | Risk reduction | ||
| Contract with transplant team (tissue bank staff) | CLO—Director, Tissue Bank staff,transplant team of the CLO | ||||
| Failure to perform tasks by the CLO transplant team. No access to biological material—allogeneic human skin | 20 | Likelihood—Likely, but impact disastrous | Risk reduction | ||
| Legal regulation of the issue of tissue procurement by non-MD personnel | CLO—Director, Tissue Bank staff,transplant team of the CLO | ||||
| Failure to perform tasks by the CLO transplant team. No access to biological material—allogeneic human skin | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction | ||
| Consent for recovery and transplantation of allogeneic skin | CLO – Director | Failure to obtain the consent of the Health Ministry and National Center for Tissue and Cell Banking for the collection and transplantation of allogeneic skin | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction |
| Other transplant centers | Failure to obtain the consent of the Health Ministry and National Center for Tissue and Cell Banking for the collection and transplantation of allogeneic skin | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction |
Identified risks in the area of preparation of allogeneic skin
| Risk area | Source/Stakeholder | Risk description | Risk assessment | Risk category | Undertaken/planned risk response |
|---|---|---|---|---|---|
| Preparation | Tissue Bank staff | Proper production | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction |
| Ensuring the required manufacturing purity | Tissue Bank Staff, cleaning staff | Cleanliness of the premises/the sterility of production will be disturbed by inadequate cleaning/cleaning of the equipment/unsuitable premises or the use of unsuitable materials | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction |
| Materials required for production | Tissue Bank staff | Not enough reagents and plastics with appropriate certificates | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction |
| Endogenous contamination | Tissue bank Staff, MD | Incorrect decontamination procedure or antiseptic that contaminates human material | 15 | Likelihood—Moderate, but impact disastrous | Risk reduction |
| Obtaining the material | Tissue Bank staff | Problems with obtaining enough material for production | 5 | Likelihood—Nearly impossible, but impact disastrous | Risk acceptance |
| Cross-contamination in Prosthetics Premises | Tissue Bank staff | 5 | Likelihood—Nearly impossible, but impact disastrous | Risk acceptance |
Identified risks in qualification and validation
| Risk area | Source/Stakeholder | Risk description | Risk assessment | Risk category | Undertaken/planned risk response |
|---|---|---|---|---|---|
| The devices will not have the appropriate documents confirming the safety of their use in the preparation process | Tissue Bank staff | Suspension or withdrawal of the authorization for the production of tissue transplants | 15 | Likelihood—Moderate, but impact disastrous | EMERGENCY BACKUP PLAN |
| Critical hardware failure | Tissue Bank staff | Wear of spare elements, mechanical wear, improper use | 12 | Likelihood—Moderate, but impact serious | EMERGENCY BACKUP PLAN |
Identified risks in documentation and quality
| Risk area | Source/Stakeholder | Risk description | Risk assessment | Risk category | Undertaken/planned risk response |
|---|---|---|---|---|---|
| Documentation and training | Tissue Bank staff | Insufficient knowledge in the field of GMP resulting in gaps in documentation or documentation not in accordance with GMP | 10 | Likelihood—Unlikely, but impact disastrous | Risk reduction |
| Securing access to documentation and manufactured products | CLO | Unauthorized access to cell/tissue material, donor and manufacturing documentation | 5 | Likelihood—nearly impossible, but impact disastrous | Risk acceptance |